GlassScriptPhysician profile
Grant C Hopping
NPI 1952922494
$1,363.81
in general payments reported to CMS, 2019-2025
17 companies · $636 in 2025
The $636 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $123 · 2024: $604 · 2025: $636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,240.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $461.67 | 2024-2025 | Clareon, Clareon Panoptix Pro |
| Dompe US, INC. | $216.85 | 2024-2025 | Oxervate |
| Bausch & Lomb Americas INC. | $138.92 | 2024-2025 | Miebo, Vyzulta |
| Horizon Therapeutics Plc | $123.46 | 2022 | |
| Sun Pharmaceutical Industries INC. | $65.98 | 2024-2025 | |
| Abbvie INC. | $57.80 | 2024-2025 | |
| Harrow Eye, LLC | $45.51 | 2024-2025 | Vevye |
| Sight Sciences, INC. | $34.31 | 2025 | Omni Surgical System |
| Johnson & Johnson Surgical Vision, INC. | $29.54 | 2025 | Tecnis Simplicity |
| Rxsight INC | $28.17 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Oyster Point Pharma, INC. | $27.17 | 2024 | Ryzumvi, Tyrvaya |
| Beaver-Visitec International, INC. | $25.15 | 2025 | |
| Glaukos Corporation | $24.36 | 2024 | Idose |
| Astellas Pharma US INC | $24.28 | 2025 | Izervay |
| Genentech USA, INC. | $21.59 | 2025 | Vabysmo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $21.06 | 2025 | Iyuzeh |
| Amgen INC. | $17.99 | 2025 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grant Hopping listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.